| Dr Shannon Lyn Schug, OD | |
|
945 Broadway St, Buffalo, NY 14212-1218 | |
| (716) 845-6080 | |
| (716) 845-0167 |
| Full Name | Dr Shannon Lyn Schug |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 17 Years |
| Location | 945 Broadway St, Buffalo, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144420142 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TUV007147-1 (New York) | Secondary |
| 152W00000X | Optometrist | 6347 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sharma Ophthalmology Pllc | 9032275979 | 4 |
News Archive
Noting the U.N. Commission on Life-Saving Commodities for Women and Children on Wednesday "released 10 bold recommendations which, if achieved, will ensure women and children will have access to 13 life-saving commodities," Jennifer Bergeson-Lockwood, a maternal health adviser with USAID, writes in USAID's "IMPACTblog" that the agency is working "to integrate systems across commodities to better and more efficiently serve women and children everywhere, and scale up programs to have nation-wide impact."
Anthony Nolan and the Anthony Nolan Research Institute have a long tradition of supporting and engaging with researchers.
Vertex Pharmaceuticals Incorporated today announced that the Therapeutic Goods Administration of Australia has approved KALYDECO (ivacaftor) for people with cystic fibrosis ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene.
Researchers are scheduled to present Phase I data relating to Semafore Pharmaceuticals' lead product candidate, SF1126, as a treatment for patients with relapsed and refractory myeloma during the 51st American Society of Hematology (ASH) Annual Meeting, December 5 - 8, 2009, at the Ernst N. Morial Convention Center in New Orleans, LA.
› Verified 3 days ago
| Provider Name | Sharma Ophthalmology Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750535282 PECOS PAC ID: 9032275979 Enrollment ID: O20090302000469 |
News Archive
Noting the U.N. Commission on Life-Saving Commodities for Women and Children on Wednesday "released 10 bold recommendations which, if achieved, will ensure women and children will have access to 13 life-saving commodities," Jennifer Bergeson-Lockwood, a maternal health adviser with USAID, writes in USAID's "IMPACTblog" that the agency is working "to integrate systems across commodities to better and more efficiently serve women and children everywhere, and scale up programs to have nation-wide impact."
Anthony Nolan and the Anthony Nolan Research Institute have a long tradition of supporting and engaging with researchers.
Vertex Pharmaceuticals Incorporated today announced that the Therapeutic Goods Administration of Australia has approved KALYDECO (ivacaftor) for people with cystic fibrosis ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene.
Researchers are scheduled to present Phase I data relating to Semafore Pharmaceuticals' lead product candidate, SF1126, as a treatment for patients with relapsed and refractory myeloma during the 51st American Society of Hematology (ASH) Annual Meeting, December 5 - 8, 2009, at the Ernst N. Morial Convention Center in New Orleans, LA.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shannon Lyn Schug, OD 6473 Pebble Ct, Medina, OH 44256-5561 Ph: (716) 713-0948 | Dr Shannon Lyn Schug, OD 945 Broadway St, Buffalo, NY 14212-1218 Ph: (716) 845-6080 |
News Archive
Noting the U.N. Commission on Life-Saving Commodities for Women and Children on Wednesday "released 10 bold recommendations which, if achieved, will ensure women and children will have access to 13 life-saving commodities," Jennifer Bergeson-Lockwood, a maternal health adviser with USAID, writes in USAID's "IMPACTblog" that the agency is working "to integrate systems across commodities to better and more efficiently serve women and children everywhere, and scale up programs to have nation-wide impact."
Anthony Nolan and the Anthony Nolan Research Institute have a long tradition of supporting and engaging with researchers.
Vertex Pharmaceuticals Incorporated today announced that the Therapeutic Goods Administration of Australia has approved KALYDECO (ivacaftor) for people with cystic fibrosis ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene.
Researchers are scheduled to present Phase I data relating to Semafore Pharmaceuticals' lead product candidate, SF1126, as a treatment for patients with relapsed and refractory myeloma during the 51st American Society of Hematology (ASH) Annual Meeting, December 5 - 8, 2009, at the Ernst N. Morial Convention Center in New Orleans, LA.
› Verified 3 days ago
Dr. Robert H Hornberger Jr., OD Optometrist Medicare: Medicare Enrolled Practice Location: 902 Main St, Buffalo, NY 14202 Phone: 716-883-9550 Fax: 716-883-9551 | |
Dilip J. Patel, M.d., P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 65 Wehrle Dr, Buffalo, NY 14225 Phone: 716-837-1090 Fax: 716-837-0023 | |
Dr. Carey Jane Murzynski, OD Optometrist Medicare: Medicare Enrolled Practice Location: 403 Main St Ste 510, Buffalo, NY 14203 Phone: 716-852-7262 | |
Eyes Exclusive Optometrist Medicare: Not Enrolled in Medicare Practice Location: 846 Main St Ste R4, Buffalo, NY 14202 Phone: 716-300-8482 Fax: 716-551-0743 | |
Richard J Schwartz Od Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2626 Delaware Ave, Buffalo, NY 14216 Phone: 716-541-9431 | |
2020 Westside Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 324 West Ferry Street, Buffalo, NY 14213 Phone: 716-883-4747 Fax: 716-883-4764 |